Lofexidine
From Wikipedia, the free encyclopedia
Lofexidine
|
|
Systematic (IUPAC) name | |
2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole | |
Identifiers | |
CAS number | ? |
ATC code | N07 |
PubChem | ? |
Chemical data | |
Formula | C11H12Cl2N2O |
Mol. mass | 259.131 g/mol |
Pharmacokinetic data | |
Bioavailability | >90% |
Protein binding | 80–90% |
Metabolism | Hepatic glucuronidation |
Half life | 11 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Oral |
Lofexidine is an alpha2-adrenergic receptor agonist, can be used as a short acting (short half life) anti-hypertensive, but mostly used to help with relief from symptoms of heroin or opiate withdrawal in opiate dependency. Used primarily in the United Kingdom [1]. See also clonidine.
Antihypertensives (C02) and diuretics (C03) | |
---|---|
Antiadrenergic agents (including alpha) | Clonidine, Doxazosin, Guanethidine, Guanfacine, Lofexidine,Mecamylamine, Methyldopa, Moxonidine, Prazosin, Rescinnamine, Reserpine |
Vasodilators | Diazoxide, Hydralazine, Minoxidil, Nitroprusside, Phentolamine |
Other antihypertensives | Bosentan, Ketanserin |
Low ceiling diuretics | Bendroflumethiazide, Chlorothiazide, Chlortalidone, Hydrochlorothiazide, Indapamide, Quinethazone, Mersalyl, Metolazone, Theobromine, Cicletanine |
High ceiling diuretics | Bumetanide, Furosemide, Torasemide |
Potassium-sparing diuretics | Amiloride, Eplerenone, Spironolactone, Triamterene |